New data concerning treatment of urogenital cancer patients presented at annual congress of American Society of Clinical Oncology 2011 Review article
Article Sidebar
Main Article Content
Abstract
INTRODUCTION: The annual congress of The American Society of Clinical Oncology took place between 03.06.2011 and 06.06.2011 in Chicago, the US.
MATERIAL AND METHODS: Papers presented during ASCO are discussed in four sections: Testicular Cancer, Prostate Cancer, Kidney Cancer and Urothelial Carcinoma.
RESULTS: About 160 original papers concerning urogenital cancers were surveyed. Phase III studies are discussed as well as the supplemental analyses of the phase III trials published during ASCO. A brief summary of phase I and phase II trials was also provided.
CONCLUSION: The ASCO Annual Congress is the conclusion of the advances in the field of medical oncology.
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)